Results 231 to 240 of about 1,686,576 (303)

Prevalence and Factors Associated With Adverse Birth Outcomes in Bangladesh: Evidence From the 2022 Demographic and Health Survey

open access: yesReproductive, Female and Child Health, Volume 5, Issue 4, December 2026.
ABSTRACT Background Adverse birth outcomes (ABOs) are a prevalent health issue that includes a number of unfavourable health consequences for both the mother and the newborn. Conditions such as still birth, low birth weight, preterm birth, and macrosomia are linked to a range of both immediate and long‐term complications. Therefore, this study aimed to
Nowshin Tabassum Shohana   +2 more
wiley   +1 more source

Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial. [PDF]

open access: yesNat Med
Skinner J   +36 more
europepmc   +1 more source

Philanthropy for the Disenfranchised

open access: yesPhilosophy &Public Affairs, Volume 54, Issue 4, Page 238-251, Fall 2026.
ABSTRACT Philanthropy has an uneasy relationship with democracy. It distributes decision‐making power plutocratically, in proportion to wealth. It allows unelected, unaccountable, and often untrustworthy individuals to shape social outcomes. And it does so in domains where democracy should be authoritative. Yet, at the same time, philanthropy does much
Jacob Barrett
wiley   +1 more source

Giovanni Antonio Scopoli's De Hydrargyro Idriensi Tentamina (1761): Mercury Mining, Mercurialism, and Preventive Reasoning in Eighteenth‐Century Occupational Medicine

open access: yesAmerican Journal of Industrial Medicine, Volume 69, Issue 11, Page 996-1004, November 2026.
ABSTRACT Giovanni Antonio Scopoli (1723–1788), a physician‐naturalist of the Enlightenment, is primarily remembered for his contributions to botany and entomology. Less attention has been paid to his medical work De hydrargyro Idriensi Tentamina physico‐chymico‐medica (1761), written during his fifteen years of service as physician at the mercury mines
Alberto Zanatta   +3 more
wiley   +1 more source

Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria

open access: yesMedicinal Research Reviews, Volume 46, Issue 6, Page 1477-1498, November 2026.
ABSTRACT Malaria is a global health threat, with an estimated 282 million cases and 610,000 malaria‐associated deaths reported in 2024. Most mortality is due to infection by Plasmodium falciparum parasites, with the highest burden occurring in Sub‐Saharan Africa.
Wisam A. Dawood   +7 more
wiley   +1 more source

Plasmepsins as Antimalarial Drug Targets—Then, Now, and the Future

open access: yesMedicinal Research Reviews, Volume 46, Issue 6, Page 1574-1602, November 2026.
ABSTRACT Malaria is a devastating disease caused by Plasmodium parasites. Plasmodium parasites express ten cathepsin D‐like aspartyl proteases, called plasmepsins (PMs). These PMs have diverse roles fulfill diverse functions throughout the parasite's lifecycle, though several exhibit functional redundancies. Among them, PMV, PMIV, and PMX are essential
Brad E. Sleebs
wiley   +1 more source

Home - About - Disclaimer - Privacy